Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial

PURPOSE: S-1 is a standard postoperative adjuvant chemotherapy for patients with stage II or III gastric cancer in Asia. Neoadjuvant or perioperative strategies dominate in Western countries, and docetaxel has recently shown significant survival benefits when combined with other standard regimens in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Kazuhiro, Kodera, Yasuhiro, Kochi, Mitsugu, Ichikawa, Wataru, Kakeji, Yoshihiro, Sano, Takeshi, Nagao, Narutoshi, Takahashi, Masazumi, Takagane, Akinori, Watanabe, Takuya, Kaji, Masahide, Okitsu, Hiroshi, Nomura, Takashi, Matsui, Takanori, Yoshikawa, Takaki, Matsuyama, Jin, Yamada, Makoto, Ito, Seiji, Takeuchi, Masahiro, Fujii, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524985/
https://www.ncbi.nlm.nih.gov/pubmed/30925125
http://dx.doi.org/10.1200/JCO.18.01138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524985/
https://www.ncbi.nlm.nih.gov/pubmed/30925125
http://dx.doi.org/10.1200/JCO.18.01138

Ejemplares similares